Navigation Links
Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies
Date:3/21/2011

a history of anaphylactic or severe systemic response to immune globulin preparations or components of Hizentra, and in persons with selective immunoglobulin A deficiency who have known antibody against IgA and a history of hypersensitivity. If anaphylactic reactions are suspected, administration should be discontinued immediately and the patient treated as medically appropriate. Because Hizentracontains the stabilizer L-proline, it is also contraindicated in patients with hyperprolinemia.

Hizentra should be administered subcutaneously only.

Hizentra is derived from human plasma. The risk of transmission of infectious agents including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be eliminated completely.

The most common drug-related adverse reactions, observed in 5 percent or more of subjects in the clinical study, were local injection-site reactions, headache, vomiting, pain, and fatigue.

Monitor patients for reactions associated with IVIg treatment that might occur with Hizentra, including renal dysfunction/failure, thrombotic events, aseptic meningitis syndrome (AMS), hemolysis and transfusion-related acute lung injury (TRALI).

For full prescribing information, visit www.hizentra.com/consumer/prescribing-information.aspx.

About CSL BehringCSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide. CSL Behring therapies are indicated for the treatment of coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies and inherited respiratory disease. The company's products are also used in cardiac surgery, organ transplantation, burn treatm
'/>"/>

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. In a Phase 2 Study PF-04523655 (RTP801I-14) Showed Improved Vision Over Standard of Care in Patients with Diabetic Macular Edema at 12 Months
2. Study of Patients on Chronic Opioid Therapy finds Likely Non-adherent Patients Have Increased Healthcare Costs, More Hospital Days
3. iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
4. Cornerstone Pharmaceuticals Announces Positive Results of Emulsiphan Safety Study
5. Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
6. Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
7. Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS Elevate Anterior and Apical Prolapse Repair System
8. BioTox Sciences (BTS) Deploys eStudy™ Hosted Solution for Management of GLP & Non-GLP Preclinical Studies
9. Positive Findings From Excellagen Matrix Clinical Study Published in Peer-Reviewed Journal Wound Repair and Regeneration
10. DATATRAK Awarded First Study With Kreara Solutions
11. Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 24 de mayo de 2013  Volcano Corporation ... y fabricante de herramientas de precisión para terapia ... de la enfermedad vascular periférica y coronaria, anunció ... Ad enosine V asodilator I ndependent ... la sesión de ensayo clínico hot line late ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical ... nurse triage and nurse advice lines, announces its ... comprising physician, nursing and administrative leaders, provides clinical ... quality and cost-effective services for hospital clients, physician ... national healthcare system evolves, it,s imperative to continuously ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4TeamHealth Medical Call Center Forms Clinical Advisory Committee 2
(Date:5/24/2013)... Mike Stoler believes that there is much ... in New York. That’s why he hosts “Building ... TV. And that’s why he invited Robert Glazer, ... (ENTA)—the largest single specialty practice in the greater New ... audiology specialists and sub-specialists service communities throughout New York ...
(Date:5/24/2013)... Seattle, WA (PRWEB) May 24, 2013 ... consider when picking out a home security monitoring ... comparisons help make 6Webs.com the useful resource consumers prefer ... recently completed performing their evaluations of the leading wireless ... home security companies are rated on a number of ...
(Date:5/24/2013)... 2013 The Dictation Source recently added ... clients. As a result of its National marketing efforts, ... 20 states around the nation. , Since 1991, The ... to the healthcare industry . Dictation Source is owned ... years of clinical work experience to provide the solutions ...
(Date:5/24/2013)... The number of U.S. patients admitted to hospitals, ... emergency room has increased by nearly 50 percent, ... by researchers at the George Washington University School ... D.C., found that patients wait five hours in ... to the ICU. The researchers said improved coordination ...
(Date:5/24/2013)... Australia (PRWEB) May 24, 2013 ... off their favorite sunglasses all while learning how ... with replacement lenses. Contestants only need to ... their sunglasses and "like" The Sunglass Fix on ... Sunglass fix is the largest lens replacement ...
Breaking Medicine News(10 mins):Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2Health News:Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win 2
... Now,s the Time to Write or Call Your Representatives, ... Although President Obama has called for affordable, accessible, high-quality ... legislation will bridge the long term care gap," says ... of our 300 million plus, have long term care ...
... (Nasdaq: PRXL ) announced today it will be ... in New York. Josef von Rickenbach, Chairman & Chief ... at 3:10 p.m. EDT on Tuesday, June 9, 2009. ... the "Investor Relations - Upcoming Events" section of ...
... Solutions, Inc. (MHS), a leader in the field of physical inventory ... Epstein Becker & Green, P.C., has joined the MHS Board of ... ... Management Health Solutions, Inc. (MHS) , a leader in the ...
... Can Test So You Can Rest , ... New York (Vocus) May 28, 2009 -- ... to it, don,t even know. Snoring is more than an annoyance. ... problems. The member dentists of Snoring Isn,t Sexy® have united to ...
... Of Every Federal And State Dollar Spent, 96 Cents Goes ... 2 Cents Goes to Prevention and TreatmentWASHINGTON, May 28 ... local governments at least $467.7 billion in 2005, according to ... Federal, State and Local Budgets, a new 287-page report ...
... you?WASHINGTON, May 27 Ariana-Leilani, "The Little Ambassador" is ... life has met with Former President Bush, Nobel Peace ... of Swaziland and the current Ambassadors to the USA ... blood disorder which could be fatal if it continues ...
Cached Medicine News:Health News:Voters Urged to Support Budding Moves to Include Long Term Care in National Health Reform 2Health News:Voters Urged to Support Budding Moves to Include Long Term Care in National Health Reform 3Health News:PAREXEL International to Present at Goldman Sachs Annual Global Healthcare Conference and the Jefferies Annual Healthcare Conference 2Health News:Steven B. Epstein Joins Board of Management Health Solutions, Inc. 2Health News:Snoring Isn't Sexy Launches Public Awareness Campaign 2Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 2Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 3Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 4Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 5Health News:Family Prayer Candle Light Vigil for Life-Saving Rescue of 6-year-old 'Little Ambassador' 2
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... The INFINITI 4F, ... of diagnostic catheters is ... These products incorporate state-of-the-art ... nylon to deliver better ...
... complete offering of cardiology catheters. Available in ... are designed with excellent torque, new wire-braid ... push-ability, and large inner lumens for excellent ... and 7 French sizes with pressure ratings ...
Medicine Products: